Market Tracker

03/05 6:39am ET

Ocata Therapeutics Inc (NASDAQ:OCAT)

6.54
Delayed Data
As of Mar 04
 -0.10 / -1.51%
Today’s Change
4.95
Today|||52-Week Range
12.73
+7.39%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close6.64
Today’s open6.60
Day’s range6.49 - 6.74
Volume131,846
Average volume (3 months)153,297
Market cap$228.4M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-51.77%
P/E ratioNM
Price/Sales683.37
Price/Book15.27

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...+0.28+2.97%
ALIMAlimera Sciences Inc+0.03+0.58%
ATHXAthersys Inc+0.06+2.06%
GALEGalena Biopharma Inc+0.10+5.41%
Data as of 03/04/2015

Financials

Last reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$225.0K
Annual profit (last year)-$31.0M
Net profit margin-13,788.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts